학술논문
Giant cell myocarditis following COVID‐19 successfully treated by immunosuppressive therapy.
Document Type
Case Study
Author
Source
Subject
*SARS-CoV-2
*IMMUNOSUPPRESSIVE agents
*COVID-19
*TREATMENT effectiveness
*MYOCARDITIS
*
*
*
*
Language
ISSN
2050-0904
Abstract
It has been shown that severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), by coronavirus disease 2019 (COVID‐19), can lead to multi‐organ impairment including cardiac involvement and immunological problems. Acute myocarditis is one of serious and fatal complications of COVID‐19. In this case report, we present a 46‐year‐old lady with a history of lichen planus dermatitis who has developed a rapidly progressive heart failure after an episode of COVID‐19. The pathologic examination of her endomyocardial biopsy specimens was compatible with GCM, and she was successfully treated with a combined immunosuppressive therapy regimen. [ABSTRACT FROM AUTHOR]